Sunday, 15 June 2025
Registration fee inclusive with Summit registration, limit to 250 seats, first come first serve.
| TIME | PROGRAMME | SPEAKER/S |
| 1200 – 1300 | Registration | |
| 1300 – 1310 | Opening Remarks | |
| Pearls in Clinical Management of Dengue | ||
| 1310 – 1320 | Introductory session, overview of dengue Introduce workshop objectives |
Dr. Fatima Gimenez |
| 1320 – 1555 | Workshops on clinical management
Classification of Dengue Diagnostics Life Stage (Infancy to Adolescent, Adult) 1. Dengue without warning signs – OPD management in the public and private setting Q & A |
c/o Dr. Janice |
| 1555 – 1610 | Coffee break | |
| 1610 – 1710 | Severe Dengue and Its Complications
Dengue in Special Populations |
|
| 1710 – 1725 | PPS Dengue Integrated Program
A program initiated by the Philippine Pediatric Society aimed at training and updating pediatricians on the advances and best practices in dengue management and community prevention, and cascading this knowledge down to the community level |
Dr. Florentina Ty |
| 1725 – 1740 | Q & A | |
| 1740 – 1750 | Summary and Conclusion | Dr. Kristine Dela Cruz |
Day 1 – Monday, 16 June 2025
| TIME | PROGRAMME | SPEAKER/S |
| 0730 – 0830 | Registration | |
| Opening Ceremonies | ||
| 0830 – 0840 | Introduction to Asia Dengue Summit
Dengue in the Philippines: A Continuing Public Health Challenge |
Dr. Maria Rosario Capeding |
| 0840 – 0850 | Keynote Address | |
| 0850 – 0910 | Professorial Lecture/Guest of Honor’s Speech
Dengue and Global Health |
|
| 0910 – 0935 | Guest of Honor’s Tour of Exhibition Ribbon CuttingCoffee Break |
|
| The evolving epidemiology of Dengue: country experiences – gains, challenges, and ways forward | ||
| 0935 – 0955 | Preview of Lancet Commission Findings | |
| 0955 – 1025 | Dengue in the Midst of Climate Change ‐ understand connection of dengue and climate change ‐ impact of climate variability on dengue transmission ‐ using climate data to predict dengue outbreaks ‐ addressing the dengue threat with climate resilience |
Panel discussion |
| 1025 – 1045 | Dengue epidemiology: modeling the future | |
| 1045 – 1105 | Dengue Pathogenesis | Prof. Ooi Eng Eong |
| 1105 – 1205 | Industry Sponsored Symposium | BioMerieux |
| 1205 – 1250 | Lunch, poster viewing, visit to exhibitors’ booths | |
| Dengue pathogenesis and management – navigating best practice options in resource-limited settings | ||
| 1250 – 1320 | Dengue viruses are not monolithic | |
| 1320 – 1405 | Updates on dengue diagnostics
Regulatory reliance and harmonization Update of diagnostics tests/systems |
Panel discussion
Dr Montoya |
| 1405 – 1450 | DNDi Sponsored-Symposium: Dengue Therapeutics – Antivirals, immunomodulators, herbal remedies | |
| 1450 – 1505 | Coffee break, poster viewing, visit to exhibitors’ booths | |
| 1505 – 1530 | Dengue Human Infection Model – Filling the Immunology Knowledge Gaps | Stephen Thomas |
| 1530 – 1630 | Best practices in clinical management of dengue: – Adult – PediatricInclude: Special populations (elderly, pregnant) Complications |
Panel Discussion
Moderator: Dr. Fatima Gimenez |
| 1630 – 1655 | Dengue Immunity – Lessons from the Field | Tineke Cantaert (Cambodia) Shelly Ylade (Philippines) |
| 1655 – 1720 | Dengue Immunity – Lessons from Clinical Trials | |
| 1720 – 1730 | Summary and close day 1 | Dr. Kristine Dela Cruz |
Day 2 – Tuesday, 17 June 2025
| TIME | PROGRAMME | SPEAKER/S |
| 0730 – 0830 | Registration | |
| 0830 – 0850 | Key learnings from the Clinical Management Workshop | |
| Dengue vaccine updates and innovations | ||
| 0850 – 0930 | How can dengue vaccines be introduced
Mass vaccination during dengue outbreak Policy making for dengue immunization |
|
| 0930 – 1020 | Real-world experience with dengue vaccine
Introducing dengue vaccine in the NIP – the Indonesian experience Introducing dengue vaccine in the private sector: Asian countries with licensed and available dengue vaccine – Malaysia, Thailand, Vietnam |
|
| 1020 – 1035 | Coffee break, poster viewing, visit to exhibitors’ booths | |
| 1035 – 1135 | Industry-sponsored Symposium B | |
| 1135 – 1220 | Lunch, poster viewing, visit to exhibitors’ booths | |
| 1220 – 1300 | Research oral presentations – by invitation | |
| Policy, Advocacy, Research and Innovation | ||
| 1300 – 1400 | Vector control and implementation
Challenges to Vector Control in the Philippines Human Movement Drives Dengue Transmission |
|
| 1400 – 1425 | Predictive modelling for prediction and prevention of dengue outbreaks | |
| 1425 – 1440 | Coffee break, poster viewing, visit to exhibitors’ booths | |
| 1440 – 1605 | Dengue Slayers Challenge (ADVA-JA) | Grand Final |
| 1605 – 1705 | Advocacy, communication and collaboration
Effective communication strategies Call to action |
Panel discussion Moderator: Dr. Lulu BravoPanel: Country expertsDr. Capt. Erica Tania Davillo PMA – lead dengue coalition Empowering Networks to Defeat Dengue |
| 1705 – 1725 | Summary and close day 2 | Dr. Francesca Pantig Dr. Maria Rosario Capeding |
Wednesday, 18 June 2025
Supported by the World Mosquito Program
Title: Operational Workshop – Integrating Wolbachia replacement into dengue prevention programs
Synopsis:
This half-day workshop will introduce the Wolbachia replacement method, highlight its impact on dengue prevention, and feature perspectives from countries on implementing Wolbachia programs. Through presentations, practical case studies, and an open Q&A, participants will:
- Increase understanding of Wolbachia-based dengue prevention, including core principles, key operational steps, and real-world impacts.
- Gain practical insights on planning, implementing, and monitoring Wolbachia replacement programs
- Learn from the experiences of countries who are implementing Wolbachia replacement programs, drawing on their successes, challenges, and lessons learned.
- Engage in discussion among public health officials, policy makers, donors, and technical experts on how Wolbachia replacement can be integrated into existing vector control programs.
Who should attend:
As spaces are limited, access will be prioritized to people working in the following areas:
- Ministry of Health officials responsible for dengue control programs
- Vector control staff wanting to understand more about implementing Wolbachia initiatives
- Donors interested in funding or supporting Wolbachia initiatives
- Representatives from regional and international health agencies and non governmental organizations
Registration Fee: Peso 500 / USD10
This workshop is limited to 50 participants, and a nominal registration fee is required to secure your spot. The fee includes a tea/coffee break and light refreshments.
Spaces are limited and will be allocated on a first-come, first-served basis, so early registration is encouraged.
For more information, contact secretariat@adva.asia or francis@adva.asia